Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation
Citations Over TimeTop 1% of 2022 papers
Abstract
As effective ways to regulate protein levels, targeted protein degradation technologies have attracted great attention in recent years. Here, we established a novel integrin-facilitated lysosomal degradation (IFLD) strategy to degrade extracellular and cell membrane proteins using bifunctional compounds as molecular degraders. By conjugation of a target protein-binding ligand with an integrin-recognition ligand, the resulting molecular degrader proved to be highly efficient to induce the internalization and subsequent degradation of extracellular or cell membrane proteins in an integrin- and lysosome-dependent manner. As demonstrated in the development of BMS-L1-RGD, which is an efficient programmed death-ligand 1 (PD-L1) degrader validated both in vitro and in vivo, the IFLD strategy expands the toolbox for regulation of secreted and membrane-associated proteins and thus has great potential to be applied in chemical biology and drug discovery.
Related Papers
- → Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery(2021)107 cited
- → Lysosome and related protein degradation technologies(2023)13 cited
- → Targeted protein degradation: Emerging concepts and protein state-specific targeting principles(2022)18 cited
- → Targeted Intracellular Protein Degradation as a Potential Therapeutic Strategy(2010)
- → Trivalent PROTACs speed up protein degradation(2021)